With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene||Baylor College of Medicine / Robin Parihar, MD, PhD||Young Investigator Grants||2015||Texas|
|High-dimensional Biochemical CyTOF Analysis of Pediatric T cell Leukemias||University of California San Francisco / Jeroen Roose, PhD||Innovation Grants||2015||California|
|Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia||University of California San Francisco / Elliot Stieglitz, MD||Young Investigator Grants||2015||California|
|CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma||Children's Hospital of Philadelphia / Robyn Sussman, PhD||Young Investigator Grants||2015||Pennsylvania|
|The Role of DEF and SSU Processome in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Ting Tao, PhD||Young Investigator Grants||2015||Massachusetts|
|Enhanced Drug Repurposing Screen in DSRCT Enabled by New In Vitro and In Vivo Models Based on CRISPR/Cas9 Genome Engineering||Memorial Sloan-Kettering Cancer Center / Marc Ladanyi, MD & Maria Jasin, PhD||Innovation Grants||2015||New York|
|Novel Nanoscale Phosphoproteomic Discovery of Therapeutic Targets in AML Stem Cells||Dana-Farber Cancer Institute / Leo Wang, MD, PhD||Young Investigator Grants||2015||Massachusetts|
|Identifying Mechanisms of Glucocorticoid Resistance in Pediatric Acute Lymphoblastic||University of Massachusetts Medical School / Michelle Kelliher, PhD||Innovation Grants||2015||Massachusetts|
|Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma||Dana-Farber Cancer Institute / Mark Kieran, MD, PhD & Dipak Panigrahy, MD||Innovation Grants||2015||Massachusetts|
|Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas||University of California, Davis Medical Center / Paul Knoepfler, PhD||Innovation Grants||2015||California|